PLSE logo

PLSE Pulse Biosciences, Inc.

NASDAQ Capital Market · Medical - Instruments & Supplies · Healthcare

$45.55
+1.14 (+2.57%)

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively el…

Market Cap: $3.35Bwww.pulsebiosciences.com

Price

No data yet.

Social Signal Score

69
5d
77
1 mentions
—
30d
67
4 mentions
—
60d
67
4 mentions
—
90d
67
5 mentions
—
news: 5

Analyst Ratings

7 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 2Sell 0Strong Sell 0
Avg price target$63.4+39.2%
Low $58Median $64High $70
Current Consensus

Revenue

$395.0K
$-9.0K$275.3K$559.7K$844.0K
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.02
$-1.67–$-0.20
1 analysts
FY2026
$-1.15
$-1.87–$-0.22
2 analysts
FY2027
$-1.25
$-2.03–$-0.24
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Paul Arthur LaViolette
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
116
Beta
1.64
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
107.62
www.pulsebiosciences.com